Brief: Endonovo Therapeutics to acquire Rio Grande Neurosciences
11/07/2016 11:15
July 11 (Reuters) - Endonovo Therapeutics Inc ENDV.PK
* Endonovo Therapeutics announces binding letter of intent
to acquire Rio Grande Neurosciences, Inc.
Source text for Eikon: ID:nMKWvn7F8a
Further company coverage: ENDV.PK
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Endonovo Therapeutics
See all newsBrief: Endonovo To Sell SofPulse Brand Business And IP To SofPulse Inc For A Minimum Of $50 Million
Brief: Endonovo’S Sofpulse® Nears Final Stages To Receive Taiwan FDA License To Distribute In Taiwan
Brief: Endonovo Therapeutics Inc - Sofpulse, Inc. Will Operate Independently After Planned Spin-Off
Brief: Endonovo Therapeutics Details Plan To Spin Off Medical Device Division As A Listed Public Company
Brief: Endonovo Announces Plan To Explore Strategic Alternatives For Its Sofpulse Medical Device Assets